SI1551414T1 - Postopek za pripravo kristalne oblike I olanzapina - Google Patents

Postopek za pripravo kristalne oblike I olanzapina

Info

Publication number
SI1551414T1
SI1551414T1 SI200332341T SI200332341T SI1551414T1 SI 1551414 T1 SI1551414 T1 SI 1551414T1 SI 200332341 T SI200332341 T SI 200332341T SI 200332341 T SI200332341 T SI 200332341T SI 1551414 T1 SI1551414 T1 SI 1551414T1
Authority
SI
Slovenia
Prior art keywords
olanzapine
preparing
crystal form
crystal
Prior art date
Application number
SI200332341T
Other languages
English (en)
Inventor
Jordan Berta Kotar
Franc Vrecer
Marija Grcman
Original Assignee
Krka, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, D.D., Novo Mesto filed Critical Krka, D.D., Novo Mesto
Publication of SI1551414T1 publication Critical patent/SI1551414T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200332341T 2002-07-15 2003-07-14 Postopek za pripravo kristalne oblike I olanzapina SI1551414T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200200175A SI21270A (sl) 2002-07-15 2002-07-15 Kristalne oblike olanzapina in postopki za njihovo pripravo
PCT/SI2003/000024 WO2004006933A2 (en) 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation
EP03764287.3A EP1551414B1 (en) 2002-07-15 2003-07-14 Process for preparing the crystal form I of olanzapine

Publications (1)

Publication Number Publication Date
SI1551414T1 true SI1551414T1 (sl) 2014-04-30

Family

ID=30113490

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200200175A SI21270A (sl) 2002-07-15 2002-07-15 Kristalne oblike olanzapina in postopki za njihovo pripravo
SI200332341T SI1551414T1 (sl) 2002-07-15 2003-07-14 Postopek za pripravo kristalne oblike I olanzapina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200200175A SI21270A (sl) 2002-07-15 2002-07-15 Kristalne oblike olanzapina in postopki za njihovo pripravo

Country Status (12)

Country Link
US (1) US7745429B2 (sl)
EP (1) EP1551414B1 (sl)
AU (1) AU2003256242A1 (sl)
CA (1) CA2493370C (sl)
EA (1) EA008055B1 (sl)
HR (1) HRP20050039B1 (sl)
NO (1) NO20050720L (sl)
PL (1) PL217081B1 (sl)
RS (1) RS53474B (sl)
SI (2) SI21270A (sl)
UA (1) UA83633C2 (sl)
WO (1) WO2004006933A2 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
AU2003300324A1 (en) * 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
AR047459A1 (es) 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)
WO2005070939A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Synthesis of olanzapine and intermediates thereof
US7906642B2 (en) * 2004-03-08 2011-03-15 Krka, Tovarna Zdravil, D.D. Isopropanol water solvate of olanzapine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
GB0522473D0 (en) 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
US7834176B2 (en) * 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU629879A3 (ru) 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US5229382A (en) 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5776928A (en) * 1995-04-21 1998-07-07 Eli Lilly And Company Method for treating dyskinesias with olanzapine
US6506746B2 (en) * 1995-05-30 2003-01-14 Eli Lilly And Company Method for treating cognitive dysfunction
ZA978515B (en) 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
BR9711541A (pt) 1996-09-23 1999-08-24 Lilly Co Eli Dihidrato d de olanzapina
AU9583498A (en) * 1997-09-30 1999-04-23 Eli Lilly And Company Method for treating sexual dysfunction
AU779452B2 (en) * 1999-12-28 2005-01-27 Cipla Limited New polymorphic forms of olanzapine
AU2001243475A1 (en) 2000-08-31 2002-03-13 Dr. Reddy's Laboratories Ltd. Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Also Published As

Publication number Publication date
CA2493370A1 (en) 2004-01-22
US7745429B2 (en) 2010-06-29
HRP20050039A2 (en) 2005-08-31
UA83633C2 (ru) 2008-08-11
WO2004006933A3 (en) 2004-04-01
NO20050720L (no) 2005-02-10
RS53474B (en) 2014-12-31
EA008055B1 (ru) 2007-02-27
HRP20050039B1 (hr) 2014-10-10
PL217081B1 (pl) 2014-06-30
EP1551414A2 (en) 2005-07-13
SI21270A (sl) 2004-02-29
WO2004006933A2 (en) 2004-01-22
RS20050023A (en) 2007-06-04
EP1551414B1 (en) 2013-11-27
CA2493370C (en) 2009-09-29
PL373845A1 (en) 2005-09-19
US20060040920A1 (en) 2006-02-23
EA200500188A1 (ru) 2005-06-30
AU2003256242A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
ZA200405256B (en) Process for the production of hydrocarbons
IL166341A (en) Pyrazole derivatives and process for the production thereof
HUP0500851A3 (en) Process for the preparation of rosuvastatin
IL176326A0 (en) Process for the production of proteins
HUP0200103A3 (en) Process for the production of virus-inactivated human gammaglobulin g
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
AU2003300324A8 (en) Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
HK1093725A1 (en) Process for the preparation of substituted thiazoles
SI1551414T1 (sl) Postopek za pripravo kristalne oblike I olanzapina
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
EP1614774A4 (en) PROCESS FOR PRODUCING A SINGLE CRYSTAL
AU2003263622A8 (en) Process for preparing prostaglandin derivatives and starting materials for the same
IL163379A (en) Continuous cell line for the production of vaccines
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
EP1679392A4 (en) PROCESS FOR PRODUCING MONOCRYSTAL
TWI319391B (en) Process for the production of 3-methylthiopropanal
GB0304927D0 (en) Process for the production of tibolone
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
AU2003278420A8 (en) Process for the preparation of ganciclovir
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
IL164788A0 (en) Process for the preparation of 3-isochromanone
IL158119A0 (en) Method for the production of delta1-pyrrolines